| Bioactivity | BI-4732 a potent inhibitor EGFR-activating (E19del and L858R) and T790M mutations, with high blood-brian barrier penetration, targeting a broad range of EGFR mutations, including C797S. BI-4732 has anti-tumor activity[1]. |
| CAS | 2769715-68-4 |
| Formula | C32H36N10O2 |
| Molar Mass | 592.69 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Eun Ji Lee, et al. Discovery of a novel potent EGFR inhibitor against EGFR activating mutations and on-target resistance in NSCLC. Clin Cancer Res. 2024 Feb 8. |
BI-4732
CAS: 2769715-68-4 F: C32H36N10O2 W: 592.69
BI-4732 a potent inhibitor EGFR-activating (E19del and L858R) and T790M mutations, with high blood-brian barrier penetra
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.